Pacific Biosciences of California Inc. buy Cantor Fitzgerald
Start price
31.10.23
/
50%
€6.27
Target price
31.10.24
€10.36
Performance (%)
-78.93%
Price
10:29
€1.32
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc. is performing very badly with a performance of -78.93%. This prediction currently runs until 31.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | -1.648% | -1.648% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.41
08.08.24
08.08.24
€3.21
08.08.25
08.08.25
-6.04%
10:29
10:29